| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.51 | 0.06 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |